Expect ‘high tide’ of Chinese biotech deals as threat of US curbs fades: analysts

By South China Morning Post | Created at 2026-09-21 10:12:07 | Updated at 2026-09-21 11:00:58 1 hour ago

0.8x0.9x1.0x1.1x1.2x1.5x1.75x

Read Entire Article